This webinar series will update you on the latest USP developments in Particulate Matters.

This webinar will focus on USP General Chapters <1>, <790> and <1790>, which address particles observed in injections in the visible range. Specific methods and requirements will be reviewed and compared with similar expectations found in the European and Japanese Pharmacopeias. Also included is a discussion about the recently released draft guidance from FDA titled Inspection of Injectable Products for Visible Particles.

Subject area:
Drug Products & APIs

Objectives (If applicable):
n/a

Target Audience (If applicable):
Laboratory scientists
Lab managers
QA/QC staff in the pharmaceutical and allied industries
Regulatory professionals
Scientists with interest in Particulate Matter